Image (C3247274 C72a 4181 9638 58f7ff14729c 01)
Deferiprone Tablet, Coated
Product Images NDC 75907-348
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Deferiprone (NDC 75907-348). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Dr. Reddy's Laboratories, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
500 (C3247274 C72a 4181 9638 58f7ff14729c 02)
This text provides information about Deferiprone tablets containing 500 mg of deferiprone. It includes instructions for pharmacists to dispense a Medication Guide to each patient. The tablets are film-coated and the usual dosage is specified in the package leaflet. The storage conditions recommend keeping the tablets at 20°C to 25°C (68°F to 77°F). The tablets are manufactured for Dr. Reddy's Laboratories, Inc. in Princeton, NJ, and are a product of India. They are manufactured by Aavis Pharmaceuticals in Hoschton, GA. The text also includes a revision date of 09/2025 and a product code.*
1000 (C3247274 C72a 4181 9638 58f7ff14729c 03)
This is a description of Deferiprone tablets in 1000 mg strength, to be taken three times a day. The package includes 50 film-coated tablets. The medication guide must be dispensed to each patient. Each tablet contains 1,000 mg of deferiprone. The usual dosage information can be found in the package leaflet. It should be stored at 20°C to 25°C with excursions permitted up to 30°C. The manufacturer is Dr. Reddy's Laboratories, Inc., with the product being manufactured by Aavis Pharmaceuticals.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
